Familial occurrence of abnormalities of high-density lipoprotein cholesterol

被引:5
作者
Kral, Brian G. [1 ]
Becker, Diane M. [1 ]
机构
[1] Johns Hopkins Med Inst, Johns Hopkins Sibling & Family Heart Study, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Apolipoprotein A-I; ATP binding cassette transporter A-I; Cholesteryl ester transfer protein; Coronary artery disease; HDL cholesterol; Hepatic lipase; LDL cholesterol; Lecithin cholesterol acyltransferase; Lipoprotein lipase; Scavenger receptor class B type I; Very-low-density lipoprotein cholesterol;
D O I
10.1016/j.jacl.2007.01.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In families, well-known monogenic high-density lipoprotein cholesterol (HDL-C) disorders characterized by extreme HDL-C levels on both ends of the continuum occur in multiple HDL pathways and can confer increased risk for atherosclerotic disease. Polygenic HDL-C variants have been more difficult to identify. In many family and twin studies in different populations, HDL-C levels have been shown to be highly heritable, explaining, on average, between 40% and 60% of between-individual variation. This review of abnormal HDL in families addresses known monogenic HDL disorders and HDL-C heritability in the general population, and presents novel data on the heritability of HDL-C in families with a history of premature coronary artery disease. We conclude that levels of HDL-C and HDL abnormalities are largely under genetic control and environmental and behavioral factors alone have only a modest impact. While rare, monogenic disorders offer considerable insight into the genetics of HDL regulation. Moderate to high heritability estimates across different family populations suggest that future genetic studies will be successful in identifying HDL genetic trait loci and that translational Studies will ultimately lead to therapies that optimize the cardiovascular protective benefits of HDL. (C) 2007 National Lipid Association. All rights reserved.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 125 条
[31]   Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population [J].
Costanza, MC ;
Cayanis, E ;
Ross, BM ;
Flaherty, MS ;
Alvin, GB ;
Das, K ;
Morabia, A .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (08) :714-724
[32]  
CRIQUI MH, 1980, CIRCULATION, V62, P70
[33]   High-density lipoproteins: an emerging target in the prevention of cardiovascular disease [J].
Cutri, Belinda A. ;
Hime, Neil J. ;
Nicholls, Stephen J. .
CELL RESEARCH, 2006, 16 (10) :799-808
[34]   A novel nonsense apolipoprotein A-I mutation (apoA-IE136X) causes low HDL cholesterol in French Canadians [J].
Dastani, Z ;
Dangoisse, C ;
Boucher, B ;
Desbiens, K ;
Krimbou, L ;
Dufour, R ;
Hegele, RA ;
Pajukanta, P ;
Engert, JC ;
Genest, J ;
Marcil, M .
ATHEROSCLEROSIS, 2006, 185 (01) :127-136
[35]   A review of CETP and its relation to atherosclerosis [J].
de Grooth, GJ ;
Klerkx, AHEM ;
Stroes, ESG ;
Stalenhoef, AFH ;
Kastelein, JJP ;
Kuivenhoven, JA .
JOURNAL OF LIPID RESEARCH, 2004, 45 (11) :1967-1974
[36]   CLONING AND SEQUENCING OF HUMAN CHOLESTERYL ESTER TRANSFER PROTEIN CDNA [J].
DRAYNA, D ;
JARNAGIN, AS ;
MCLEAN, J ;
HENZEL, W ;
KOHR, W ;
FIELDING, C ;
LAWN, R .
NATURE, 1987, 327 (6123) :632-634
[37]   Dyslipidaemia [J].
Durrington, P .
LANCET, 2003, 362 (9385) :717-731
[38]  
Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477
[39]   Pleiotropic genetic effects on LDL size, plasma, triglyceride, and HDL cholesterol in families [J].
Edwards, KL ;
Mahaney, MC ;
Motulsky, AG ;
Austin, MA .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2456-2464
[40]   Prognostic value of cholesterol in women of different ages [J].
Emond, MJ ;
Zareba, W .
JOURNAL OF WOMENS HEALTH, 1997, 6 (03) :295-307